Literature DB >> 17499553

Current treatment options for abnormal uterine bleeding: an evidence-based approach.

Olav Istre1, Erik Qvigstad.   

Abstract

Heavy menstrual bleeding is the predominant complaint in women with abnormal uterine bleeding. Treatment options are drug therapy, and first- and second-generation endometrial resection. Many women will subsequently have a hysterectomy. Uterine fibroids are the most common solid pelvic tumours in women, and although many fibroids seem to cause no symptoms, they can have serious adverse effects and impact on quality of life. As women postpone having children, gynaecologists will have to manage fibroids and polyps in a conservative manner. The past decade has witnessed the development of highly sophisticated diagnostic and therapeutic technology for women suffering from menorrhagia, fibroids and polyps, including minimally invasive uterine therapy. The tools currently at our disposal permit greater management flexibility, which must be tailored to the individual clinical situation. This chapter reviews the evidence-based approach and minimally invasive therapy.

Entities:  

Mesh:

Year:  2007        PMID: 17499553     DOI: 10.1016/j.bpobgyn.2007.03.021

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  2 in total

1.  Implementation of uterine artery embolization for symptomatic fibroids in the Netherlands: an inventory and preference study.

Authors:  Annefleur M de Bruijn; Jolijn Huisman; Wouter J K Hehenkamp; Paul N M Lohle; Jim A Reekers; Anne Timmermans; Andries R H Twijnstra
Journal:  CVIR Endovasc       Date:  2019-06-03

2.  Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system.

Authors:  Chandra Kailasam; David Cahill
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.